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The conserved Paf1 complex (Paf1C) carries out multiple functions during transcription by RNA polymerase (pol) II, and these
functions are required for the proper expression of numerous genes in yeast and metazoans. In the elongation stage of the
transcription cycle, the Paf1C associates with RNA pol II, interacts with other transcription elongation factors, and facilitates
modiﬁcations to the chromatin template. At the end of elongation, the Paf1C plays an important role in the termination of RNA
pol II transcripts and the recruitment of proteins required for proper RNA 3 end formation. Signiﬁcantly, defects in the Paf1C are
associated with several human diseases. In this paper, we summarize current knowledge on the roles of the Paf1C in RNA pol II
transcription.
1.Introduction
The RNA pol II transcription cycle can be divided into
three primary stages: initiation, elongation, and termination.
During transcription initiation, the binding of the TATA-
binding protein (TBP) subunit of TFIID to the promoter
triggers the assembly of a preinitiation complex, which
contains RNA pol II and the general transcription factors,
TFIIA, TFIIB, TFIID, TFIIE, TFIIF, and TFIIH (reviewed
in [1]). The general transcription factors position the
polymerase at the transcription start site and unwind the
DNA to expose the template strand for RNA synthesis
(reviewed in [1]). During transcription elongation, multiple
regulatory proteins associate with RNA pol II to facilitate its
progressionandmodifythechromatintemplate(reviewedin
[2]).Finally,duringRNA3 endformationandtranscription
termination, the transcript is processed and released through
the combined actions of multiple RNA processing factors
(reviewed in [3]). Therefore, each stage of the transcription
cycle is regulated by a plethora of proteins to ensure proper
gene expression.
The regulation of transcription initiation is an important
aspect of controlling gene expression and has thus been
studied for many years. More recently, the regulation of pos-
tinitiation stages has been shown to be equally important for
ensuring proper gene expression. Furthermore, eukaryotic
cells have evolved many mechanisms to overcome the barri-
ersimposedbychromatinonallthreestagesofthetranscrip-
tion cycle. One highly conserved protein complex that lies at
the intersection between chromatin modiﬁcation pathways
and transcription is the Paf1C. This complex associates with
RNApolII[4–7]andinﬂuencesmultipleeventsduringtran-
scription elongation, including the posttranslational modiﬁ-
cationof histone proteins [8–12]andtherecruitmentofpro-
teins required for RNA processing [13–16]. Not surprisingly
given its key regulatory roles, the Paf1C and its functions are
conserved throughout eukaryotes. Here, we review current
knowledge on the Paf1C, emphasizing insights that have
emerged from genetic and biochemical studies in budding
yeast and also discussing more recent observations made in
multicellular eukaryotes, where defects in the complex lead
to developmental abnormalities and disease.2 Genetics Research International
2.InitialStudiesinYeastLedto
the Discovery of the Paf1C andRevealed
Its Roles inTranscriptionElongation
The search for accessory proteins that cooperate with general
transcription factors and regulate transcription initiation
prompted experiments that led to the identiﬁcation of Paf1
(polymerase-associated factor 1) in Saccharomyces cerevisiae
[7,17].Asthenameimplies,Paf1wasfoundtoassociatewith
RNA pol II by aﬃnity chromatography [17]. Subsequent
studies demonstrated that Paf1 exists in a nuclear complex
with Ctr9, Cdc73, Rtf1, and Leo1 [4, 18–20]. Prior to the
discovery that they interacted with Paf1, other members
of the Paf1C were identiﬁed through yeast genetics and
recognized for their potential roles in transcription. For
example, the CTR9 gene (Cln three (CLN3) requiring 9)
was originally identiﬁed by its genetic interaction with CLN3
[21] and subsequently identiﬁed in a genetic screen for
mutants with impaired transcription of G1 cyclin genes
[22]. Additionally, RTF1 (Restores TBP function 1) was
originally discovered in a genetic selection for mutations
that suppress transcriptional defects caused by TBP mutants
with altered DNA binding speciﬁcity [23]. Cdc73 (Cell
division cycle 73) [24] and Leo1 (Left open reading frame
1) [25] may not have been initially recognized for their roles
in transcription, but were subsequently determined to be
important transcriptional regulators in the context of the
Paf1C.
Paf1Csubunitshavebeenimplicatedintranscriptionini-
tiation by inﬂuencing the phenotypic eﬀects of a TBP-altered
speciﬁcity mutant [23] and in transcription termination and
RNA 3 end formation by mediating recruitment of 3 end
processing factors [13–16]. However, the Paf1C is currently
best characterized for its critical roles during transcription
elongation. Initial studies revealed that genetic disruption
of the yeast Paf1C causes phenotypes associated with tran-
scriptionelongationdefects.Forexample,S.cerevisiaestrains
lacking Paf1C subunits exhibit sensitivity to 6-azauracil (6-
AU) and mycophenolic acid (MPA) [20, 26]. These drugs
reduce intracellular nucleotide pools, which is thought to
increase polymerase pausing, making transcription more
dependent on regulatory factors [27]. Consistent with these
phenotypes, Paf1C members genetically and physically inter-
act with elongation factors such as the Spt4-Spt5 (yDSIF)
and Spt16-Pob3 (yFACT) complexes, suggesting that these
complexes function cooperatively to modulate transcription
elongation [4, 20, 26]. In agreement with the genetic data, a
recently described transcription run-on assay revealed tran-
scription elongation defects in the absence of Paf1C subunits
in vivo [28]. Despite the strong evidence currently linking
the Paf1C to the control of transcription elongation, a less
direct role in regulating gene expression was also proposed
in an earlier study [29]. The lack of an eﬀect of rtf1Δ and
cdc73Δ mutations on in vivo elongation rates or RNA pol II
processivity, as measured on an inducible long gene, led to
the conclusion that the Paf1C inﬂuenced cotranscriptional
processes. Indeed, the Paf1C has been implicated in several
cotranscriptional processes, including the phosphorylation
of RNA pol II during elongation and the recruitment of
a chromatin-remodeling enzyme, Chd1, to open reading
frames [13, 30, 31]. Additionally, in its best-understood
role, the Paf1C is important for the establishment of
cotranscriptional histone modiﬁcations that inﬂuence gene
expression [8–12]. Together, these observations suggest that
the Paf1C inﬂuences gene expression through multiple
functions during transcription (Figure 1). In this paper, we
describe current information on these functions.
3.The Paf1C AssociateswithRNA Pol IIand
Inﬂuences the Phosphorylation State of the
RNA Pol IICTD
The Paf1C accompanies the polymerase from the transcrip-
tion start site to the poly(A) site [5, 32]. Rtf1 and Cdc73 are
bothrequiredforthephysicalassociationofPaf1CwithRNA
pol II. In rtf1Δ or cdc73Δ cells, the remaining Paf1C subunits
dissociate from the polymerase and chromatin, even though
these subunits remain associated in a subcomplex [13, 31,
33]. Deletion analysis of S. cerevisiae RTF1 deﬁned a central
region of the Rtf1 protein (amino acids 201 to 395), termed
the ORF association region (OAR), that is required for the
physicalassociationbetweenthePaf1Candactivegenes[34].
Although an NMR study has provided important structural
information on the human Rtf1 OAR, also known as a Plus3
domain [35], the manner in which Rtf1 interacts with RNA
pol II is unknown. Recombinant Cdc73 can interact with
puriﬁed RNA pol II, suggesting that Cdc73 may directly
contact RNA pol II in vivo [19]. Beyond the interactions of
Rtf1andCdc73withRNApolII,Leo1isalsorequiredforfull
association of the Paf1C with active genes [36]. In this case,
evidence suggests that an interaction between Leo1 and the
nascent mRNA stabilizes the association of the Paf1C with
transcribed genes [36].
The interaction between Paf1C subunits and elongating
RNA pol II is modulated by other transcription elongation
factors. Several reports demonstrated that the Spt4-Spt5
complex promotes recruitment of the Paf1C to chromatin
[33, 37–39]. Interestingly, recent studies suggest that the
functional interactions between the Paf1C, Spt4-Spt5, and
RNA polymerase are conserved beyond RNA pol II and
are important for RNA pol I transcription as well [40–
44]. Although their roles in Paf1C recruitment are less well
characterized than that of Spt4-Spt5, the Spt6, FACT, and
Ccr4-Not transcription factors have also been shown to
modulate recruitment of the Paf1C to active genes [45–47].
The C-terminal domain (CTD) of the largest subunit
of RNA pol II, Rpb1, consists of tandemly repeated copies
of a heptapeptide sequence (YSPTSPS) that can be phos-
phorylated on the serines at positions 2, 5, and 7 of
the repeat. Importantly, the phosphorylation state of the
CTD changes throughout the transcription cycle and is
important for recruiting the appropriate regulatory factors
during eachstageoftranscription (reviewedin[48]).During
initiation, the RNA pol II CTD is hypophosphorylated.
Upon the transition from initiation to early elongation,





















Figure 1: The multiple functions of the Paf1C. During transcription elongation, the Paf1C (a) associates with RNA pol II on coding regions
[4, 6], (b) regulates histone modiﬁcations [8–12] (discussed in detail in Figure 2), and (c) recruits Chd1, an ATP-dependent chromatin
remodeling enzyme [131, 132]. (d) During a later stage of transcription elongation, the Paf1C promotes phosphorylation of serine 2 of the
RNA pol II CTD [13, 31]. (e) Additionally, the Paf1C is important for proper transcription termination and RNA 3 end formation of both
polyadenylated and nonpolyadenylated transcripts [13–16, 31].
(Kin28 in yeast) of the general transcription factor TFIIH
[49]. Phosphorylated serine 5 is recognized by the mRNA
cappingmachinery,thuscoordinatingmRNA5 endcapping
and early transcription elongation [50]. In yeast, phos-
phorylation of serine 5 can be reversed by Ssu72 and
tends to decline as elongation proceeds [51]. Serine 7 of
the CTD repeats is also phosphorylated by Kin28 [52–
54]. Patterns of serine 5 and 7 phosphorylation overlap
across genes; however, the elucidation of the functions of
serine 7 phosphorylation is still at an early stage [52–
55]. Later in elongation, serine 2 of the CTD becomes
phosphorylated mainly by Ctk1 in yeast or P-TEFb in
human cells [56, 57]. Serine 2 phosphorylation promotes
the recruitment of cleavage and polyadenylation factors to
RNA pol II, connecting the later stages of elongation to RNA
3 end processing [58, 59]. Through mechanisms that are
undeﬁned, the Paf1C is required for normal levels of serine
2 phosphorylation [13, 31]. In addition to termination and
RNA 3 end formation factors, serine 2 phosphorylation
recruits the histone H3 lysine (K) 36 methyltransferase, Set2
[60–63]. Therefore, the Paf1C most likely impacts these
processes, in part, through inﬂuencing CTD phosphoryla-
tion.
4. The Paf1C Inﬂuences GeneExpression by
PromotingHistoneH2BK123Ubiquitylation
andHistone H3K4 and K79 Methylation
During transcription elongation, RNA pol II encounters
obstacles in the form of nucleosomes, the basic units of
chromatin. Nucleosomes consist of two copies of each of the
four histone proteins, H2A, H2B, H3, and H4, in a globular
arrangement, wrapped by 147 base pairs of DNA [64, 65]. A
large amount of evidence indicates that nucleosomes impede
transcription elongation. For example, elongation eﬃciency
is severely reduced during transcription of reconstituted
chromatin templates compared to naked DNA in vitro
[66, 67]. Furthermore, in vivo, transcription rates inversely
correlate with nucleosome occupancy within open reading
frames (ORFs) [68] .I nar e c e n ts t u d yt h a te m p l o y e da
deep-sequencing-based method to determine the positions
o fa l la c t i v eR N Ap o lI Im o l e c u l e s ,e x t e n s i v ep a u s i n ga n d
backtracking of the polymerase were observed throughout
the bodies of genes [69]. Paused polymerase was particularly
noticeable at the positions of the ﬁrst four nucleosomes,
conﬁrming that nucleosomes act as a barrier to transcription




















Figure 2: The Paf1C promotes histone H2B monoubiquitylation and histone H3 K4, K36, and K79 methylation. In yeast, the ubiquitin
conjugatingenzyme,Rad6,andtheubiquitinligase,Bre1,monoubiquitylateH2BK123[179–181].H2Bmonoubiquitylationisaprerequisite
for di- and trimethylation of H3 K4 and K79 by the histone methyltransferases Set1 and Dot1, respectively [71, 80, 182, 183]. Histone H3 is
methylated on K36 by the methyltransferase Set2 [184]. Paf1 and Rtf1 subunits of the Paf1C are required for H2B K123 monoubiquitylation
and the downstream di- and trimethylation of H3 K4 and K79 [9–12]. Paf1 and Ctr9 are required for trimethylation of K36 on histone H3
[8].
Histone proteins are subject to a wide variety of
posttranslational modiﬁcations, including the acetylation,
ubiquitylation, and methylation of lysine residues. These
modiﬁcations regulate RNA pol II activity at all stages of
the transcription cycle. Members of the Paf1C are required
for several histone modiﬁcations that are associated with
active transcription (Figure 2). Speciﬁcally, Paf1 and Rtf1
are required for the monoubiquitylation of H2B on K123
in yeast (K120 in humans) [12, 37, 70] and the subsequent
di- and trimethylation of H3 K4 and K79 [9–11, 71]. Paf1
and Rtf1 promote H2B monoubiquitylation by facilitating
the association of Rad6 with RNA pol II during transcription
elongation [9–12, 70]. An in vitro assay using puriﬁed factors
revealed a direct interaction between the Paf1C and Bre1
[72]; therefore, the Paf1C may tether Rad6 and Bre1 to the
elongatingpolymerase.Sincepaf1Δcellshavegreatlyreduced
levels of Rtf1 protein, Rtf1 is probably the primary subunit
that promotes H2B monoubiquitylation and subsequent
m e t h y l a t i o no fH 3o nK 4a n dK 7 9[ 13]. In fact, mutational
studies have shown that amino acids 62–152 of S. cerevisiae
Rtf1 are required for these histone modiﬁcations, leading to
the deﬁnition of a histone modiﬁcation domain (HMD) in
Rtf1 [34, 73].
H2B K123 ubiquitylation and H3 K4 and K79 methy-
lation are enriched on the coding regions of active genes
[70, 74, 75]. Consistent with a positive role in tran-
scription, H2B monoubiquitylation has been shown to
enhance the transcription elongation rate of a chromatin
template in vitro [47]. In vivo, H2B K123 ubiquitylation
facilitates transcription of galactose-inducible genes in yeast
by promoting nucleosome-reassembly in the wake of RNA
pol II in cooperation with the histone chaperone, Spt16
[76]. Additionally, a recent study using chemically deﬁned
nucleosome arrays demonstrated that H2B ubiquitylation
interferes with chromatin compaction, which may facilitate
transcription [77].
H2B K123 ubiquitylation and the downstream methyla-
tion of H3 on K4 and K79 regulate the silencing of reporter
genes positioned near telomeres and other heterochromatic
loci within the yeast genome [10, 78–83]. In S. cerevisiae, the
silencing of genes near telomeres, and at the HMR, HML,
and rDNA loci, is mediated by silent information regulator
(Sir) proteins, which preferentially bind to hypomethylated
histones (reviewed in [84]). The genome-wide loss of H3
K4 and K79 methylation has been proposed to cause a
redistribution of Sir proteins from the silent loci, resulting in
the loss of Sir-dependent transcriptional silencing (reviewed
in [85]). Paf1 and Rtf1 are required for silencing of a
telomere-proximal reporter gene in yeast [9, 10, 34, 73].
However, recent studies indicate that caution should be
exercised in generalizing results obtained with the widely
used URA3-based silencing reporter assays. In these studies,
a dot1Δ mutation, which has been reported to cause a strong
defect in telomeric silencing based on the reporter assays,Genetics Research International 5
does not alleviate repression of natural genes near telomeres
or lead to global changes in Sir protein occupancy [86, 87].
Based on these new observations, more work will be needed
to clarify the roles of the Paf1C and its dependent histone
modiﬁcations in heterochromatic gene silencing.
Microarray analysis of transcript levels in cells lacking
the H2B ubiquitylation site (htb1-K123R substitution) has
shown that H2B K123 ubiquitylation represses many genes
throughout the yeast genome [88]. In fact, the majority
of aﬀected genes exhibited increased expression in htb1-
K123R cells, indicating that this modiﬁcation predominantly
acts to repress transcription [88]. Consistent with repressive
functions, reversal of H2B K123 ubiquitylation by the de-
ubiquitylating enzyme, Ubp8, is required for full expression
of certain inducible genes, including GAL1, GAL10,a n d
SUC2 [89–91]. Furthermore, the Paf1C mediates repression
of a subset of genes, including the ARG1 gene, by facilitating
H2B K123 ubiquitylation [92]. These observations sug-
gest that Paf1C-dependent H2B ubiquitylation has impor-
tant functions for repression of global transcription. The
mechanism by which H2B monoubiquitylation represses
transcription is not completely understood. However, H2B
monoubiquitylation has been shown to increase nucleosome
stability at the promoters of repressed genes [93]a n d
antagonize the recruitment of the positive transcription
elongation factor TFIIS to genes in human cells [94].
Importantly, like its yeast counterpart, the human Paf1C
controls gene expression through H2B monoubiquitylation
a n dH 3K 4a n dK 7 9m e t h y l a t i o n[ 47, 95–98]. Furthermore,
H2B monoubiquitylation in humans also has both positive
and negative eﬀects on transcription. For example, H2B
monoubiquitylation is preferentially associated with highly
expressed genes [97]. In addition, this modiﬁcation has
been shown to stimulate proper HOX gene expression in
human cells [98] and the transcription of pluripotency
genes in embryonic stem cells [95], thus promoting proper
development and stem cell identity, respectively. However,
de-ubiquitylation of H2B by Usp22, the human homolog of
yeastUbp8,inhibitsheterochromaticsilencingandpromotes
gene activation [99, 100]. Human Bre1/RNF20 acts as a
tumor suppressor by promoting transcription of tumor
suppressor genes and repressing proto-oncogenes, under-
scoring the importance of both positive and negative gene
regulation by H2B monoubiquitylation [101]. Collectively,
these observations indicate that H2B monoubiquitylation
has important eﬀects on gene expression in both yeast and
humans.
5. The Paf1C Promotes HistoneH3 K36
Trimethylation and Affects Histone
Acetylation Levels on Genes
In addition to methylation of H3 K4 and K79, Paf1 and
Ctr9 are required for trimethylation of H3 K36 by the
histone methyltransferase, Set2 [8]. Set2 associates with the
elongating form of RNA pol II in the body of actively
transcribed genes in a Paf1C-dependent manner [8, 60, 63].
As stated above, the Paf1C may inﬂuence Set2 recruitment
indirectly through its eﬀects on CTD phosphorylation [13,
31]. Both H3 K4 and K36 methylation occur across most
genes in a distinct pattern that is inﬂuenced by the phos-
phorylation state of the RNA pol II CTD (Figure 3). Serine
5 phosphorylation by Kin28 recruits Set1 to RNA pol II early
in elongation, resulting in a peak of H3 K4 trimethylation
near promoters [11]. Just downstream, K4 dimethylation
peaks in 5 coding regions, whereas K4 monomethylation
occurs across the gene [102, 103]. Later in elongation, serine
2 phosphorylation of the RNA pol II CTD recruits Set2,
resulting in H3 K36 methylation toward the 3 end of the
coding region [60–63].
Interestingly, H3 K4 and K36 methylation modulate
histone acetylation by facilitating the recruitment or activity
of histone acetyltransferase (HAT) and histone deacetylase
complexes (HDACs). H3 K4 trimethylation recruits the
NuA3 HAT complex, resulting in increased H3 K14 acety-
lation [104, 105]. Dimethylation of H3 K4 stimulates the
activity of the Set3 HDAC [106, 107]. Consistent with this
pathway of H3 K4 methylation-directed deacetylation, the
loss of Paf1 results in increased acetylation at 5 coding
regions [8]. Histone H3 K36 dimethylation promotes the
activity of the Rpd3S HDAC [108–111]. Through these
pathways, H3 methylation restricts histone acetylation to
promoters to prevent inappropriate transcription from
cryptic start sites internal to coding regions and restore
chromatin in the wake of the polymerase. Analysis of paf1Δ
set2Δ double mutant strains suggests that Paf1 and Set2
function separately to reduce cryptic initiation and histone
acetylation at 3 coding regions [8]. These results may not
be surprising since Paf1 is selectively required for H3 K36
trimethylation [8], yet dimethylation is suﬃcient for Rpd3S
HDAC activity [111]. Therefore, at 5 coding regions, the
Paf1C reduces histone acetylation, possibly through H3 K4
methylation-mediated deacetylation by Set3. However, at 3
coding regions, the Paf1C reduces acetylation through an
undeﬁned mechanism that is parallel to the established Set2-
Rpd3S pathway.
Given its important roles in modulating several histone
modiﬁcations, the Paf1C likely regulates gene expression by
promoting histone modiﬁcations. However, while genome-
wide analysis identiﬁed numerous genes that require the
Paf1C for proper expression [14] ,o n l yas u b s e to fP a f 1 C -
responsive genes exhibit altered expression in the absence
of these same histone modiﬁcations [88]. Therefore, the
Paf1C likely has roles aside from facilitating histone mod-
iﬁcations that control gene expression. Consistent with
this hypothesis, the repressive eﬀect of the yeast Paf1C on
ARG1 transcription can be only partially explained by a
loss of histone modiﬁcations [92]. Furthermore, in vitro
transcription elongation assays have revealed a role for the
Paf1C in stimulating transcription elongation of naked DNA
templatesbybothRNApolIandpolII[44,112].Thehistone
modiﬁcation-independent functions of the Paf1C may be
conserved throughout eukaryotes, as the human Paf1C has
recently been shown to stimulate in vitro transcription of a
chromatin template independently of histone modiﬁcations
[113]. Further investigation is required to elucidate critical
histone modiﬁcation-independent functions of the Paf1C.6 Genetics Research International
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Figure 3: Typical distribution of histone modiﬁcations across a gene. Serine 5 phosphorylation on the RNA pol II CTD recruits Set1 to RNA
pol II early in elongation, resulting in a peak of H3 K4 trimethylation near promoters [11]. Just downstream, K4 dimethylation peaks in 5
codingregions[102,103].Laterinelongation,serine2phosphorylationoftheRNApolIICTDrecruitsSet2,resultinginH3K36methylation
toward the 3 end of the coding region [60–63]. H3 K4 trimethylation recruits the NuA3 histone acetyltransferase (HAT) complex, resulting
in increased H3 K14 acetylation near the promoter [104, 105]. Within the coding region, dimethylation of H3 K4 promotes the activity of
the Set3 histone deacetylase complex (HDAC) [106, 107]. At the 3 coding region, H3 K36 dimethylation promotes the activity of the Rpd3S
HDAC [108–111]. Through these mechanisms, histone acetylation levels are maintained at low levels on coding regions.
6. The Paf1C Functions Cooperatively
withOther FactorsThat Inﬂuence
ChromatinStructure
Beyond inﬂuencing gene expression through establishing
histone modiﬁcations, the Paf1C interacts physically and
genetically with several factors that inﬂuence chromatin
structure and transcription elongation, including the elon-
gation complex Spt4-Spt5, the histone chaperone FACT, and
the chromatin remodeler Chd1. Spt4-Spt5 is required for
the recruitment of the Paf1C to the elongation complex and
for H2B K123 ubiquitylation [33, 37–39]. Paf1C recruit-
ment is regulated by phosphorylation of Spt5 by the Bur1
kinase [37–39]. Consistent with cooperative functions, the
human Paf1C, Spt4-Spt5/DSIF, and Tat-SF1 cooperatively
stimulate transcription elongation in vitro and promote
transcription in vivo [114]. A recent study involving a novel
transcription elongation reporter template demonstrated
that Spt4 and the Paf1C facilitate elongation in yeast
cells [28]. However, biochemical experiments in yeast and
human cells have shown that Spt4-Spt5/DSIF interacts with
RNA pol II during elongation and has both positive and
negative eﬀects on elongation [4, 115–118]. Although the
functions of Spt4-Spt5/DSIF are not completely understood,
genetic interactions with elongation and chromatin-related
factors suggest that Spt4-Spt5/DSIF regulates transcription
elongation through the modulation of chromatin structure.
For example, in yeast Spt4-Spt5 genetically interacts with
the ATP-dependent chromatin remodeler, Chd1 [30, 119],
and kinases and phosphatases that modify the CTD of
RNA pol II [120]. Spt4-Spt5 has been shown to recruit the
Rpd3S HDAC to active genes in cooperation with Kin28
and Ctk1 [121]. Therefore, Spt4-Spt5 may aﬀect chromatin
in part by recruiting the Rpd3S HDAC. However, in vitro
transcription using a naked DNA template has shown
that the Paf1C and DSIF can also stimulate transcription
elongation independently of chromatin [114].
The yeast Paf1C physically and genetically interacts with
Spt16-Pob3/FACT [20, 26]. Consistent with this, the human
Paf1C augments FACT-stimulated in vitro transcription of
a chromatin template [47]. FACT was originally identiﬁed
as a factor that facilitates transcription of a reconstituted
chromatin template [67, 122]. Beyond this, many physical
and genetic interactions suggest that Spt16-Pob3/FACT has
important roles during transcription [20, 26, 30, 122, 123].
It is now known that FACT directly participates in the
reorganization of nucleosomes within the ORFs of actively
transcribed genes and reassembles chromatin in the wake
of RNA pol II [123–127]. In vitro binding of an H2A-H2B
dimerbyFACT hasledtotheconclusionthatFACT displaces
a single H2A-H2B dimer to allow RNA pol II passage
[122, 128, 129]. However, analysis of nucleosomes by in
vitrohydroxyl radical accessibility and endonuclease cleavage
experiments showed that FACT creates more accessibility
than could be explained by the loss of an H2A-H2B dimer,
yet partially protects nucleosomal DNA [130]. These results
haveledtoasecondmodelforFACTfunctioninwhichFACT
performs a more dramatic reorganization of the nucleosome
without histone eviction.
In addition to its physical interactions with Spt4-Spt5
and FACT, the Paf1C interacts with Chd1, a conserved
ATP-dependent chromatin remodeling enzyme [131, 132].
Chd1 associates with regions of active transcription [30,
133] and physically interacts with Spt4-Spt5/DSIF, FACT,
and the Paf1C [4, 30, 134], pointing to an important role
during transcription elongation. The mechanistic details of
chromatin remodeling by Chd1 are not well understood.
However, Chd1 has been shown to create a chromatin
structure that inhibits cryptic transcription initiation [119].
Chd1 contains two N-terminal chromodomains, a centralGenetics Research International 7
ATPase domain and a C-terminal DNA-binding domain
[135]. Interestingly, structural studies revealed that the two
Chd1 chromodomains regulate the ATPase motor in a
unique manner. Speciﬁcally, in the absence of nucleosome
binding, the chromodomains physically block the ATPase
domain, preventing association with naked DNA [136].
Chromodomains also bind methylated lysines [137]. It has
been shown that the human homolog of Chd1 associates
with chromatin by recognition of H3 K4 methylation [138,
139], but there are diﬀering reports as to whether this occurs
in yeast [138–140]. Instead, the Rtf1 subunit of the Paf1C in
yeasthasbeenshowntorecruitChd1tochromatinthrougha
region of Rtf1 distinct from its histone modiﬁcation domain
[30, 34].
7. The Paf1C Coordinates Transcription
Elongation with Transcription Termination
andRNA 3 EndProcessing
In addition to its critical functions during transcription
elongation, the Paf1C is important for proper transcription
termination and RNA 3 end formation [13–16, 31]. The
loss of Paf1C members results in shorter poly(A) tail
lengths [13]. Additionally, the Paf1C has been shown to
modulate expression of a subset of genes, not by regulating
elongation, but by controlling poly(A) site usage [14].
Speciﬁcally, the loss of Paf1 results in the read-through of
poly(A) sites, producing 3-extended transcripts that are
subject to nonsense-mediated decay [14]. Termination and
RNA 3 end processing defects that occur in the absence
of Paf1 can be attributed to the reduced recruitment of
3 end processing factors to chromatin. In the absence
of Paf1C members, altered poly(A) site usage is associ-
ated with reduced chromatin association of the cleavage
and polyadenylation factor Pcf11 [13]. Additionally, Cft1,
another 3 end processing factor, associates with RNA pol
II in a Paf1C-dependent manner [31]. The recruitment of
cleavage and polyadenylation factors to RNA pol II and
chromatin requires the serine 2-phosphorylated form of the
RNApolIICTD[58,141].Therefore,thePaf1Cmayregulate
the recruitment of 3 end processing factors indirectly
through its eﬀectson CTD phosphorylation. However, direct
interactions between the Paf1C and 3 end processing factors
have been demonstrated in yeast and humans [31, 142].
Therefore, the Paf1C may recruit 3 end processing factors
through a mechanism that does not rely on RNA pol II CTD
phosphorylation.
Together, these observations suggest that the Paf1C plays
an important role in coordinating transcription with RNA
3 end processing. Given that the Paf1C is required for
the recruitment of 3 end processing factors to chromatin
[13, 31], yet it dissociates from RNA pol II shortly after the
poly(A) site has been transcribed [5, 32], the Paf1C appears
to participate in an exchange of elongation factors for 3
end processing factors during transcription termination.
Consistent with this hypothesis, when dissociated from
chromatin, the Paf1C associates with RNA processing factors
[31]. However, the exact mechanism by which the Paf1C reg-
ulates termination and 3 end processing of polyadenylated
transcripts remains unclear.
The Paf1C is also required for proper termination and
3 end formation of nonpolyadenylated transcripts [15].
The loss of Paf1C members or Paf1C-dependent histone
modiﬁcations results in the synthesis of small nucleolar
RNAs (snoRNAs) extended at their 3 ends [15, 73]. snoRNA
termination defects in the absence of Paf1C members are
associated with reduced recruitment of the 3 end processing
factors, Nrd1 and Nab3 [15]. Therefore, similar to its eﬀects
on the termination of polyadenylated transcripts, the Paf1C
mediates snoRNA termination by promoting recruitment of
3 end processing factors. Interestingly, it has recently been
shown that the termination function of the Paf1C can be
inhibited through an interaction with an activator [143].
Speciﬁcally, a physical interaction between Mpk1 MAPK
and Paf1 prevents premature transcription termination by
inhibiting recruitment of the Sen1-Nrd1-Nab3 complex
[143]. However, the mechanism by which the Paf1C recruits
3 end processing factors for termination remains to be
revealed. Additionally, disruption of the Rtf1 HMD results in
snoRNA termination defects, implicating H2B K123 ubiqui-
tylation in the regulation of transcription termination [73].
Interestingly, nucleosome depletion in terminator regions
has been shown to require RNA pol II transcription [144].
Therefore, in addition to facilitating recruitment of 3 end
processing factors, the Paf1C promotes proper transcription
terminationthroughH2Bmonoubiquitylationanditseﬀects
on chromatin structure.
The contribution of the Paf1C to transcription termi-
nation has yet to be assessed on a genome-wide scale.
However, given the essential roles of transcription termi-
nation, which include regulating transcript stability and
RNA pol II recycling (reviewed in [145–148]), Paf1C-
dependent termination is likely to have wide-spread eﬀects
on gene expression. Importantly, the functions of the Paf1C
in regulating termination and RNA 3 end formation are
conserved from yeast to humans [142, 149].
8. The Paf1C HasCriticalFunctions
inMetazoans
As mentioned above, the known functions of the Paf1C,
including RNA pol II-association [150] and roles in tran-
scription elongation [113, 114], histone modiﬁcation [95,
96, 98, 142], and RNA 3 end formation [142, 149], are
conserved between yeast and humans. However, there are
somediﬀerencesincomplexcomposition inyeastandhigher
eukaryotes. In humans, the Paf1C is minimally composed of
Paf1, Ctr9, Cdc73, Leo1, and the higher eukaryote-speciﬁc
subunit, Ski8, which is involved in mRNA surveillance [150–
152] .Af e wr e p o r t sd i ﬀer on whether human Rtf1 is absent
from [98, 150, 151] or present in [113] the human complex.
Therefore, human Rtf1 appears to be less stably associated
with the Paf1C. Consistent with this, Rtf1 is not stably asso-
ciated with the Drosophila Paf1C [153]. However, despite its
less stable association with the Paf1C, human Rtf1 still inﬂu-
ences gene expression and histone modiﬁcation [95, 154].8 Genetics Research International
The Paf1C has evolved critical functions in higher
eukaryotes, including promoting proper development,
maintaining pluripotency in stem cells, and preventing
cancer. Consistent with an important role in development,
the human Paf1C is required for proper transcription of
Wnt target genes [155]a n dHOX genes [98]. Additionally,
Rtf1 regulates the transcription of Notch target genes in
Drosophila and zebraﬁsh [153, 156, 157]. Given the regula-
tion of important developmental genes, it is not surprising
that, in zebraﬁsh, the Paf1C is required for the development
of the ears, neural crest, and heart [156, 158]. For proper
heart development, the Paf1C is critical for the speciﬁcation
of cardiomyocytes and patterning of the primitive heart
[159]. In addition to genes required for proper development,
the human Paf1C regulates the expression of interleukin-
6 responsive inﬂammatory genes [160] and those that
maintain pluripotency in stem cells [95].
Members of the human Paf1C have also been implicated
in cancer. Pancreatic diﬀerentiation factor 2/Paf1 is overex-
pressed in pancreatic cancer cell lines and overexpression in
cell culture results in transformation [161]. Additionally, the
gene encoding human Paf1 is ampliﬁed in many cancers,
including breast and uterine cancers [162, 163]. Further-
more, paraﬁbromin/Cdc73 is a tumor suppressor encoded
by HRPT2, a gene that is mutated in hyperparathyroidism-
jaw tumor syndrome [164–166]. The roles of the Paf1C
in preventing cancer are not entirely understood. However,
the Paf1C promotes leukemogenesis through interactions
with MLL-rearranged oncoproteins, a topic which has been
recently reviewed [167].
Like the yeast counterpart, the human Paf1C inﬂuences
gene expression by facilitating histone modiﬁcations. For
example, the Paf1C, H2B monoubiquitylation, and H3 K4
and K79 methylation promote HOX gene expression [98].
H2B monoubiquitylation also appears to play a role in main-
taining pluripotency in stem cells, and the Paf1C promotes
the transcription of genes required for pluripotency in both
mouse and human embryonic stem cells [95, 168]. Cell
diﬀerentiationisassociatedwithreducedexpressionofPaf1C
subunits [95, 168]a n dr e d u c e dl e v e l so fH 2 Bu b i q u i t y l a t i o n
[169]. Interestingly, the silencing of pluripotency genes
upon diﬀerentiation may be accomplished by the interaction
betweenthePaf1CandDNAmethyltransferases[170],which
repress these genes [171].
In addition to its eﬀects on histone modiﬁcations, the
human Paf1C regulates gene expression through direct inter-
actions with gene-speciﬁc activators. Human Ctr9 associates
with Stat3 and recruits it to the promoters of interleukin-
6 responsive genes [160]. Cdc73 in humans promotes
the transcription of Wnt target genes through a direct
interaction with β-catenin [155]. Additionally, the Paf1C is
found in a complex with the transactivator Tat to promote
transcription from the HIV-1 promoter [172].
9. Conclusions andFutureStudies
The Paf1C performs multiple functions during RNA pol
II transcription, and these functions are conserved from
yeast to humans. Previous studies have provided a wealth of
knowledge about the roles of the Paf1C in transcriptional
regulation; however, many important questions remain.
While it is known that the Paf1C associates with RNA poly-
merase during elongation and dissociates near the poly(A)
site, the details of the Paf1C-RNA pol II interaction, and its
regulation, remain undeﬁned. Current information suggests
thattheassociationofthePaf1CwithRNApolIIisfacilitated
by multiple interactions. Cdc73 and Rtf1 play nonredundant
roles in tethering the Paf1C to RNA pol II, but it is unclear
whether these proteins make direct or indirect contacts with
the polymerase or whether, like Leo1 [36], interactions with
the nascent transcript are involved. Furthermore, although
phosphorylation of Spt5 stimulates Paf1C recruitment [37–
39], the regulatory events that promote dissociation of the
Paf1C near the poly(A) site have yet to be elucidated.
A requirement for the Paf1C in regulating transcription
termination and RNA 3 end formation has been observed
at speciﬁc genes. However, determining the scope of this
eﬀect on RNA 3 end formation or other steps in RNA
maturation will require additional genome-wide studies
on Paf1C-deﬁcient cells. Existing data indicate that the
Paf1C mediates transcription termination in several ways.
Its physical association with RNA processing factors suggests
that the Paf1C coordinates the exchange of transcription
elongation factors for transcription termination and 3 end
processing factors [31], although the mechanisms remain to
be characterized. Additionally, the transcription termination
functions of the Paf1C correlate with its roles in promoting
serine 2 phosphorylation of the RNA pol II CTD [13, 31]
and H2B ubiquitylation [73]. It is not known whether the
Paf1C promotes phosphorylation of serine 2 by aﬀecting
the recruitment and/or activity of the CTD kinase, Ctk1.
Furthermore, the mechanisms by which the Paf1C promotes
histonemodiﬁcationshavenotbeenthoroughlyinvestigated.
While the Paf1C facilitates the recruitment of histone
modifyingenzymestoORFs[9–12,70],themoleculardetails
of these interactions are uncharacterized, and it is uncertain
whether the Paf1C plays a role in histone modiﬁcation
beyond simply recruiting the active players. Finally, while
both positive and negative eﬀects on gene expression have
been described for the Paf1C [14, 17, 92, 173] and its
downstream histone modiﬁcations [88, 92], the features of a
gene that confer Paf1C-dependent expression are unknown.
In the case of the H2B ubiquitylation mark, it would be
especially interesting to know why some genes are repressed
by this modiﬁcation, while others are activated by it [88,
92].
AlthoughithasbeenshownthatthePaf1Cisrequiredfor
proper expression of numerous genes throughout the yeast
genome [14], a role in regulating the expression of noncod-
ing RNAs (ncRNAs) has not been determined. In addition
to genome-wide analyses unexpectedly localizing RNA pol
II to intergenic regions [174], genome-wide transcription
analyses have revealed that up to 85% of the yeast genome
is transcribed [175, 176]. Similar results were obtained in
human cells, such that ncRNAs account for a large portion
of the transcription observed [175–178]. Many ncRNAs arise
from start sites within intergenic regions and overlap withGenetics Research International 9
coding genes [175, 176]. Importantly, ncRNAs are becoming
increasingly recognized as key regulators of gene expression.
Therefore, to fully appreciate the mechanisms by which the
Paf1Cregulatesgeneexpression,itwillbeimportanttoknow
how its functions impact ncRNA synthesis. Upcoming inves-
tigations, which incorporate a multidisciplinary approach of
structural, genetic, biochemical, and genomic experiments,
will likely further establish the Paf1C as a critical regulator of
gene expression, uncover new activities of the complex, and
elucidate the molecular mechanisms of Paf1C-dependent
functions that are crucial for the prevention of cancer and
developmental defects.
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